Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Cole

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
HIV Medicine|January 17, 2025
Breaking down global barriers: A multinational and multi-community approach to combat stigma and enhance mental wellbeing in people with HIVNtombenhle Mkhize, Jorge Garrido, Susan Cole-Haley, et al.
Current Issues in Molecular Biology|August 28, 2024
Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive CrisesEssam Kerwash, Marija Sajic, Khadija Rerhou Rantell, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 6, 2011
Full efficacy with no CNS side-effects: unachievable panacea or reality? DMPK considerations in design of drugs with limited brain penetrationSusan Cole, Sharan Bagal, Ayman El-Kattan, et al.
Journal of Chemical Information and Modeling|January 24, 2007
Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemesYuan H Zhao, Michael H Abraham, Adam Ibrahim, et al.
The Oncologist|April 14, 2020
EMA Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX-351) for the Treatment of Adults with Newly Diagnosed, Therapy-Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia-Related ChangesKyriaki Tzogani, Karri Penttilä, Tuomo Lapveteläinen, et al.
Journal of Clinical Pharmacology|March 21, 2009
Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approachesNatilie A Hosea, Wendy T Collard, Susan Cole, et al.
Gates Open Research|July 22, 2024
Demystifying physiologically based pharmacokinetic modelling among non-modelers towards model-informed medicine use in under-served populationsJolien Freriksen, Joyce van der Heijden, Marika de Hoop-Sommen, et al.
Journal of Medicinal Chemistry|November 5, 2016
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of PainSarah E Skerratt, Mark Andrews, Sharan K Bagal, et al.
Nature Cell Biology|December 8, 2015
Sequential Notch activation regulates ventricular chamber developmentGaetano D'Amato, Guillermo Luxán, Gonzalo del Monte-Nieto, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 3, 2024
Covariate modeling in pharmacometrics: General points for considerationKinjal Sanghavi, Jakob Ribbing, James A Rogers, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
HIV Medicine|January 17, 2025
Breaking down global barriers: A multinational and multi-community approach to combat stigma and enhance mental wellbeing in people with HIVNtombenhle Mkhize, Jorge Garrido, Susan Cole-Haley, et al.
Current Issues in Molecular Biology|August 28, 2024
Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive CrisesEssam Kerwash, Marija Sajic, Khadija Rerhou Rantell, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 6, 2011
Full efficacy with no CNS side-effects: unachievable panacea or reality? DMPK considerations in design of drugs with limited brain penetrationSusan Cole, Sharan Bagal, Ayman El-Kattan, et al.
Journal of Chemical Information and Modeling|January 24, 2007
Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemesYuan H Zhao, Michael H Abraham, Adam Ibrahim, et al.
The Oncologist|April 14, 2020
EMA Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX-351) for the Treatment of Adults with Newly Diagnosed, Therapy-Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia-Related ChangesKyriaki Tzogani, Karri Penttilä, Tuomo Lapveteläinen, et al.
Journal of Clinical Pharmacology|March 21, 2009
Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approachesNatilie A Hosea, Wendy T Collard, Susan Cole, et al.
Gates Open Research|July 22, 2024
Demystifying physiologically based pharmacokinetic modelling among non-modelers towards model-informed medicine use in under-served populationsJolien Freriksen, Joyce van der Heijden, Marika de Hoop-Sommen, et al.
Journal of Medicinal Chemistry|November 5, 2016
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of PainSarah E Skerratt, Mark Andrews, Sharan K Bagal, et al.
Nature Cell Biology|December 8, 2015
Sequential Notch activation regulates ventricular chamber developmentGaetano D'Amato, Guillermo Luxán, Gonzalo del Monte-Nieto, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 3, 2024
Covariate modeling in pharmacometrics: General points for considerationKinjal Sanghavi, Jakob Ribbing, James A Rogers, et al.
Pageof 4